Industry

– EMPA-KIDNEY, the largest and broadest dedicated SGLT2 inhibitor trial in chronic kidney disease, provides new evidence for patients commonly seen in clinical practice1,2 – Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause,1,2 bringing potential relief for patients and reducing burden on healthcare systems3 OXFORD, England & INGELHEIM, … [Read more…]

Significant Reductions of Disease Manifestations in Proprietary Mouse Renal Model of APOL1-Mediated Kidney Disease Observed New Research Shows APOL1 p.N264K Variant Associated with Reduced Risk of Chronic Kidney Disease and End Stage Kidney Disease Among Carriers of APOL1 High-risk Variants SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Maze Therapeutics, a company translating genetic insights into new precision medicines, … [Read more…]

TORONTO–(BUSINESS WIRE)–$KONEF #psychedelics–The Women in Psychedelics Network (“WIPN” or “Network”), a network of professionals from all corners of the psychedelic industry strengthening women’s voices and providing opportunities to move mental health solutions forward, today announced atai Life Sciences N.V. (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, … [Read more…]

NEW YORK–(BUSINESS WIRE)–Flatiron Health is pleased to announce their attendance and presence at the ISPOR, The Professional Society for Health Economics and Outcomes Research Europe 2022 Conference, held in Vienna, Austria this year. A total of 7 presentations will be presented by Flatiron, including one oral podium presentation and one in-person poster being recognized as … [Read more…]

Science of Patient Input Provides a Systematic Approach to Collect, Analyze, and Apply Patient Preferences into the Medical Device Development and Regulatory Process ARLINGTON, Va.–(BUSINESS WIRE)–A Medical Device Innovation Consortium (MDIC) program today released a new framework that provides U.S. medical device companies a systematic approach for patient-focused clinical trial design to better meet patient … [Read more…]

Led by Blue Heron Capital, the new funding will accelerate team and product expansion to bring affordable at-home hearing technology and care to millions of older adults in the U.S. NEW YORK–(BUSINESS WIRE)–Yes Hearing, the leading provider of affordable, accessible, and convenient hearing technology and audiology care, today announced that it closed a $10M Series … [Read more…]

Former Doctor On Demand CEO, Hill Ferguson, steps down SAN FRANCISCO–(BUSINESS WIRE)–Included Health, the first company to fully integrate navigation and virtual care, today announced the appointment of Michael Bender to the company’s Board of Directors. The board will continue with seven seats. At the same time Hill Ferguson, former chief executive officer of Doctor … [Read more…]

SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its third quarter financial results for the period ended September 30, 2022, on Wednesday, November 9, 2022, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to … [Read more…]

BOSTON–(BUSINESS WIRE)–MassChallenge, the global network for innovators, and MITRE, an operator of federally funded R&D centers, are partnering to launch a new mentorship program designed to lower barriers for underrepresented founders in the entrepreneurial ecosystem. Applicants must have at least one founder from historically underrepresented identities including Black, Indigenous, People of Color (BIPOC), non-binary, and/or … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Paracetamol IV Market Research Report by Indication, Application, End-use, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Paracetamol IV Market size was estimated at USD 821.23 million in 2021, USD 878.46 million in 2022, and is projected to grow at a … [Read more…]